Team & Contact

Tom Schwarz, partner, possesses seed and early stage investment and corporate experience. Tom was co-founder, general partner of Life Sciences Partners, a biotech venture capital fund with offices in Amsterdam, Munich and Boston, where he focused on early stage investments in the Benelux. Tom has served on the supervisory boards of many biotech companies and is a board member for Biopartner Start-up Ventures, and a former member of the EVCA High Tech Committee. In 1997, Tom sold U-Gene Research, a company he spun-out of the University of Utrecht, to Kendle, a leading US clinical research organisation. Tom started his career at Interpharm, one of the largest pharmaceutical wholesalers in the Netherlands. He was trained as a pharmacist at the University of Utrecht.
T +31 (0)6 53 27 92 43
E-mail tschwarz[at]lsfamsterdam.nl

Harm de Vries, partner, has extensive experience in structuring, establishing, and monitoring venture capital transactions. In 2005, Harm authored the venture capital handbook “Venture Capital Term Sheets, a guide to structuring and negotiating venture capital transactions”, published by Reed Business Information. Harm started his career as an attorney at law at an international law firm in Amsterdam and was admitted to the Amsterdam bar in 1995. Harm holds a masters degree in business law from the Erasmus University of Rotterdam, the Netherlands.
T +31 (0)6 53 21 63 39
E-mail hdevries[at]lsfamsterdam.nl

Website: www.lsfamsterdam.nl